December 2025
The global thoracic outlet syndrome market size is evaluated at USD 234.18 million in 2025 and is predicted to hit around USD 415.83 million by 2035, growing at a CAGR of 5.91%.
September 2026
The global systemic inflammatory response syndrome treatment market size is estimated to hit around USD 25.84 billion by 2035 increasing from USD 16.02 billion in 2026, with a CAGR of 5.98%.
September 2026
The global genitourinary syndrome of menopause (GSM) market size was evaluated at USD 1.72 billion in 2026 and is predicted to hit around USD 3.21 billion by 2035, growing at a CAGR of 7.20%.
September 2026
The U.S. systemic inflammatory response syndrome treatment market generated USD 5.28 billion in 2026, with prominent U.S. systemic inflammatory response syndrome treatment market companies including GlaxoSmithKline, AstraZeneca, CytoSorbents Corporation.
September 2026
The global polycystic ovarian syndrome treatment market size was evaluated at USD 5.50 billion in 2026 and is predicted to hit around USD 9.21 billion by 2034, growing at a CAGR of 6.64%.
June 2026
The global guillain barre syndrome diagnostics market size is estimated to hit around USD 206.70 million by 2035 increasing from USD 154.02 million in 2025, with a CAGR of 2.99%.
July 2025
The global brugada syndrome market size was evaluated at USD 1.28 billion in 2024 and is predicted to hit around USD 2.25 billion by 2034, growing at a CAGR of 5.79%.
July 2025
The global thoracic surgery devices market size is calculated at USD 790.92 million in 2024 and is projected to hit around USD 1,466.18 million by 2034 with a CAGR of 6.37%.
July 2025
The global compartment syndrome monitoring devices market size is expected to surge around USD 438.41 million by 2034, from USD 215.93 billion in 2024 with a CAGR of 7.55%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com